Translation Services and the Race for a Coronavirus Vaccine
With hundreds of coronavirus clinical studies underway, what role does the language industry play in facilitating the search for a vaccine? Where does linguistic validation fit in?
*New* Slator Pro Guide: Scaling an LSP Key Account — Growing Small Clients into Key Accounts
pharmaceutical
Deadline 2020: What LSPs Need to Know About the EU’s New Medical Device Regulation
Europe’s new medical device regulation requires that labeling, packaging, and other content be translated into the official language of each EU country where the device will be sold.
Honyaku Center Posts Decline in Translation Revenues for H1 FY 2020
Honyaku Center reports decline in all sectors of core Translation Business, except for Patents. Banks on “active use” of machine translation to grow.
Shares in Japan’s Largest LSP Plummet on Declining Q1 FY20 Revenues
Shares in Japanese language service provider Honyaku Center plummet on declining Q1 2020 sales. Its largest unit, Translation, retreated across all sectors bar Patents.
Slator 2019 Life Sciences Translation Report
Slator’s 2019 report on the clinical life sciences translation industry, analysis of the competitive landscape and actionable insights from major buyers of pharmaceutical translation.
Why Linguistic Validation Requires Not Just Conceptual but Cultural Equivalence
Adelina Lear of contract research organization ICON plc spoke at SlatorCon London on the role of language services and the linguistic validation workflow in clinical trials.
Translation Fail Puts Chinese Pharma Company in US Regulator’s Crosshairs
Hydrocortisone or Dexamethasone? A Guangdong-based Chinese drug manufacturer gets a warning letter from the US Food and Drug Administration over a translation mistake in the label of an over-the-counter drug exported to the US.
Your information will not be shared with third parties. No Spam.